Navigation Links
Reportlinker Adds Biotechnology Pharmaceutical Market in US -2013
Date:9/7/2010

NEW YORK, Sept. 7 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Biotechnology Pharmaceutical Market in US -2013

http://www.reportlinker.com/p0289797/Biotechnology-Pharmaceutical-Market-in-US-2009-2013.html

Biotechnology Pharmaceutical Market in US 2009-2013 report by Technavio Insights forecasts the Biotechnology Pharmaceutical market to grow at a CAGR of 7.7 percent, with Blood Modifiers accounting for the largest share of the market at 36.3 percent.

The major growth drivers include:- Increasing demand for biotechnology drugs with enhanced efficiency, safety and popularity

- Revision of regulations and standards in favour of biotechnology drugs are encouraging more companies to invest in the field

- Increasing ageing population and the prevalence of chronic and age related illnesses is also driving the demand for biotechnology pharmaceuticals

However, the market is faced with some challenges which can inhibit the growth, such as the increasing healthcare expenditure in the US. Many biotechnology pharmaceutical companies are facing cost containment pressure. Lack of technical development and expertise is an issue as these companies need to employ highly skilled medical professionals.

For the purpose of this report, the Biotechnology Pharmaceutical market refers to drugs, medicines or vaccines developed through biotechnology such as recombinant DNA technology, combinatorial chemistry, gene therapy, and monoclonal antibodies. The report analyzes Biotechnology Pharmaceutical market's recent performance and provides the US market revenue and growth rates from 2009 through to 2013. It also provides detailed market segmentation based on the type of disease the drugs are formulated to treat or based on therapeutic class. The report includes comprehensive analysis of various trends and changes taking place in the Biotechnology Pharmaceutical market in the US.

It also explains the factors influencing market growth and also inhibitors preventing their adoption. The report provides basic profiles of some of the leading vendors in the market

1. Introduction

2. Market Size and Forecast

3. Market Segmentation

4. Market Trends in Biotechnology Pharmaceutical in US

5. Market Drivers in Biotechnology Pharmaceutical in US

6. Market Challenges in Biotechnology Pharmaceutical in US

7. Vendors

8. Related Reports in this Series

List of ExhibitsExhibit 2.1: Biotechnology Pharmaceutical in US Market Size and Forecast 2009-2013 (In $billion)

Exhibit 3.1: US Biotechnology Pharmaceutical Market Segmentation -2009

To order this report:Biotechnology Industry: Biotechnology Pharmaceutical Market in US -2013

Biotechnology Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Reportlinker Adds US Vaccines Market
2. Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies
3. Reportlinker Adds Womens Infertility - Pipeline Assessment and Market Forecasts to 2017
4. Reportlinker Adds Womens Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets
5. Reportlinker Adds Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies
6. Reportlinker Adds Commercializing Peptides in Oncology: A Decision Support Tool for Optimizing the Pipeline
7. Reportlinker Adds Protein Kinase Therapeutics in Oncology - Where to Commercialize?
8. Reportlinker Adds Target Atlas: Competitive Insights to Anti-Angiogenic Drug R&D in Oncology
9. Reportlinker Adds Advances in Biopharmaceutical Technology in China
10. Reportlinker Adds Bioinformatics Market - Advanced Technologies, Global Forecast and Winning Imperatives (2009 - 2014)
11. Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2017)... ... August 21, 2017 , ... Today Aether announced that ... funded by a Bill and Melinda Gates Foundation grant, to pursue a ... Melinda Gates Foundation, also known as the Gates Foundation, is said to be the ...
(Date:8/16/2017)... ... 16, 2017 , ... Tunnell Consulting announced today that four of ... Annual Meeting and Expo , to be held October 29 through November 1 in ... innovation to advance patient therapies.” , The ISPE Annual Meeting and Expo will feature ...
(Date:8/16/2017)... ... August 16, 2017 , ... We ... Drug Administration (FDA) inspection at our Dilworth, MN site. The inspection took place ... inspection was conducted as part of a routine Bioresearch Monitoring Program (BIMO) with ...
(Date:8/15/2017)... ... August 15, 2017 , ... ... that accelerate pharmaceutical and biotherapeutics development, announces the launch of the new ... needed to gain kinetic binding data for a wide range of molecules, including ...
Breaking Biology Technology:
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ... appointment of independent Directors Mr. Robin D. Richards ... Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive ... their guidance and benefiting from their considerable expertise as we ...
(Date:4/5/2017)... KEY FINDINGS The global market for stem ... 25.76% during the forecast period of 2017-2025. The rise ... growth of the stem cell market. Download ... The global stem cell market is segmented on the ... cell market of the product is segmented into adult ...
(Date:3/30/2017)... , March 30, 2017 The research team ... for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D fingerprint ... new realm of speed and accuracy for use in identification, crime ... affordable cost. ... A ...
Breaking Biology News(10 mins):